These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 21885976)

  • 1. An update on an immune system that goes awry in systemic sclerosis.
    van Bon L; Cossu M; Radstake TR
    Curr Opin Rheumatol; 2011 Nov; 23(6):505-10. PubMed ID: 21885976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct evolution of TLR-mediated dendritic cell cytokine secretion in patients with limited and diffuse cutaneous systemic sclerosis.
    van Bon L; Popa C; Huijbens R; Vonk M; York M; Simms R; Hesselstrand R; Wuttge DM; Lafyatis R; Radstake TR
    Ann Rheum Dis; 2010 Aug; 69(8):1539-47. PubMed ID: 20498209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell abnormalities in systemic sclerosis with a focus on Th17 cells.
    Brembilla NC; Chizzolini C
    Eur Cytokine Netw; 2012; 23(4):128-39. PubMed ID: 23360781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists.
    York MR; Nagai T; Mangini AJ; Lemaire R; van Seventer JM; Lafyatis R
    Arthritis Rheum; 2007 Mar; 56(3):1010-20. PubMed ID: 17328080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of toll-like receptors in systemic sclerosis.
    Ciechomska M; Cant R; Finnigan J; van Laar JM; O'Reilly S
    Expert Rev Mol Med; 2013 Aug; 15():e9. PubMed ID: 23985302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptor-dependent activation of antigen-presenting cells affects adaptive immunity to Helicobacter pylori.
    Rad R; Brenner L; Krug A; Voland P; Mages J; Lang R; Schwendy S; Reindl W; Dossumbekova A; Ballhorn W; Wagner H; Schmid RM; Bauer S; Prinz C
    Gastroenterology; 2007 Jul; 133(1):150-163.e3. PubMed ID: 17631139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innate immunity in systemic sclerosis pathogenesis.
    O'Reilly S
    Clin Sci (Lond); 2014 Mar; 126(5):329-37. PubMed ID: 24219159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced interleukin-10 production by dendritic cells upon stimulation with Toll-like receptor 4 agonists in systemic sclerosis that is possibly implicated in CCL18 secretion.
    van Lieshout AW; Vonk MC; Bredie SJ; Joosten LB; Netea MG; van Riel PL; Lafyatis R; van den Hoogen FH; Radstake TR
    Scand J Rheumatol; 2009; 38(4):282-90. PubMed ID: 19255934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
    Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
    Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergism of Toll-like receptor-induced interleukin-12p70 secretion by monocyte-derived dendritic cells is mediated through p38 MAPK and lowers the threshold of T-helper cell type 1 responses.
    Bohnenkamp HR; Papazisis KT; Burchell JM; Taylor-Papadimitriou J
    Cell Immunol; 2007 Jun; 247(2):72-84. PubMed ID: 17927969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Toll-like receptor-driven innate immunity in thoracic organ transplantation.
    Goldstein DR; Palmer SM
    J Heart Lung Transplant; 2005 Nov; 24(11):1721-9. PubMed ID: 16297771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphatase PTP1B negatively regulates MyD88- and TRIF-dependent proinflammatory cytokine and type I interferon production in TLR-triggered macrophages.
    Xu H; An H; Hou J; Han C; Wang P; Yu Y; Cao X
    Mol Immunol; 2008 Aug; 45(13):3545-52. PubMed ID: 18571728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrosis and immune dysregulation in systemic sclerosis.
    Chizzolini C; Brembilla NC; Montanari E; Truchetet ME
    Autoimmun Rev; 2011 Mar; 10(5):276-81. PubMed ID: 20863906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptor signaling and regulation of cytokine gene expression in the immune system.
    Ozato K; Tsujimura H; Tamura T
    Biotechniques; 2002 Oct; Suppl():66-8, 70, 72 passim. PubMed ID: 12395929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered B lymphocyte function induces systemic autoimmunity in systemic sclerosis.
    Sato S; Fujimoto M; Hasegawa M; Takehara K; Tedder TF
    Mol Immunol; 2004 Nov; 41(12):1123-33. PubMed ID: 15482848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innate Immunity in Systemic Sclerosis.
    Dowson C; Simpson N; Duffy L; O'Reilly S
    Curr Rheumatol Rep; 2017 Jan; 19(1):2. PubMed ID: 28116578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel insights on the role of the innate immune system in systemic sclerosis.
    York MR
    Expert Rev Clin Immunol; 2011 Jul; 7(4):481-9. PubMed ID: 21790291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of IL-13 in systemic sclerosis.
    Fuschiotti P
    Cytokine; 2011 Dec; 56(3):544-9. PubMed ID: 21920770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Innate immunity: structure and function of TLRs].
    Delneste Y; Beauvillain C; Jeannin P
    Med Sci (Paris); 2007 Jan; 23(1):67-73. PubMed ID: 17212934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.